| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 43 | 2021 | 428 | 2.910 |
Why?
|
| Parathyroid Neoplasms | 16 | 2016 | 60 | 1.780 |
Why?
|
| Parathyroidectomy | 17 | 2019 | 80 | 1.630 |
Why?
|
| Hyperparathyroidism, Primary | 6 | 2019 | 45 | 1.320 |
Why?
|
| Parathyroid Hormone | 25 | 2019 | 221 | 1.210 |
Why?
|
| Adenoma | 15 | 2015 | 250 | 1.170 |
Why?
|
| Carcinoma, Papillary | 14 | 2017 | 157 | 1.130 |
Why?
|
| Hyperparathyroidism | 21 | 2002 | 67 | 1.130 |
Why?
|
| Streptococcus pyogenes | 14 | 2003 | 35 | 1.070 |
Why?
|
| Thyroidectomy | 24 | 2021 | 171 | 0.940 |
Why?
|
| Carcinoma | 17 | 2015 | 438 | 0.930 |
Why?
|
| Calcium | 41 | 2016 | 1183 | 0.820 |
Why?
|
| Genes, ras | 7 | 1997 | 97 | 0.770 |
Why?
|
| Pancreatic Neoplasms | 17 | 2020 | 686 | 0.720 |
Why?
|
| Streptococcal Infections | 14 | 2003 | 55 | 0.720 |
Why?
|
| Hypocalcemia | 16 | 2018 | 44 | 0.670 |
Why?
|
| Thyroid Gland | 20 | 2017 | 281 | 0.660 |
Why?
|
| Hyperparathyroidism, Secondary | 6 | 2018 | 69 | 0.630 |
Why?
|
| Parathyroid Glands | 22 | 2014 | 74 | 0.600 |
Why?
|
| Adenocarcinoma, Follicular | 7 | 2017 | 55 | 0.570 |
Why?
|
| Adenoma, Islet Cell | 14 | 1993 | 28 | 0.530 |
Why?
|
| Recurrent Laryngeal Nerve | 2 | 2009 | 11 | 0.530 |
Why?
|
| Neoplasms, Radiation-Induced | 5 | 2016 | 95 | 0.500 |
Why?
|
| Male | 131 | 2021 | 42967 | 0.500 |
Why?
|
| Female | 129 | 2021 | 46894 | 0.500 |
Why?
|
| Adult | 107 | 2018 | 26953 | 0.490 |
Why?
|
| Humans | 183 | 2021 | 90640 | 0.480 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2014 | 19 | 0.480 |
Why?
|
| Middle Aged | 93 | 2020 | 26347 | 0.460 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 2014 | 15 | 0.440 |
Why?
|
| Pharyngitis | 5 | 2001 | 15 | 0.420 |
Why?
|
| Radiopharmaceuticals | 4 | 2014 | 198 | 0.410 |
Why?
|
| Muscle Weakness | 2 | 2012 | 62 | 0.370 |
Why?
|
| Aged | 65 | 2020 | 19424 | 0.370 |
Why?
|
| Penicillin V | 3 | 2001 | 3 | 0.370 |
Why?
|
| Quality of Life | 7 | 2020 | 1693 | 0.360 |
Why?
|
| Thyroid Nodule | 3 | 2017 | 62 | 0.360 |
Why?
|
| Point Mutation | 3 | 1997 | 246 | 0.350 |
Why?
|
| Hypercalcemia | 5 | 2008 | 63 | 0.350 |
Why?
|
| Carcinoid Tumor | 7 | 1997 | 45 | 0.340 |
Why?
|
| Adrenal Gland Neoplasms | 6 | 2016 | 81 | 0.340 |
Why?
|
| Graves Disease | 11 | 1997 | 36 | 0.330 |
Why?
|
| Zollinger-Ellison Syndrome | 9 | 1990 | 10 | 0.330 |
Why?
|
| Adolescent | 42 | 2021 | 9354 | 0.320 |
Why?
|
| Medical Illustration | 1 | 2009 | 16 | 0.320 |
Why?
|
| Dissection | 1 | 2009 | 44 | 0.320 |
Why?
|
| Penicillin G Benzathine | 3 | 2001 | 5 | 0.310 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 1882 | 0.310 |
Why?
|
| Retrospective Studies | 25 | 2020 | 9330 | 0.310 |
Why?
|
| Kidney Failure, Chronic | 5 | 2014 | 417 | 0.310 |
Why?
|
| Intestinal Neoplasms | 4 | 2020 | 69 | 0.310 |
Why?
|
| Child | 36 | 2021 | 7219 | 0.300 |
Why?
|
| Postoperative Complications | 12 | 2020 | 2342 | 0.290 |
Why?
|
| Familial Mediterranean Fever | 1 | 2007 | 4 | 0.290 |
Why?
|
| Adenocarcinoma | 6 | 2017 | 1182 | 0.280 |
Why?
|
| Incidence | 15 | 2016 | 1594 | 0.280 |
Why?
|
| Muscular Diseases | 1 | 2007 | 64 | 0.280 |
Why?
|
| Cancer Survivors | 2 | 2018 | 63 | 0.270 |
Why?
|
| Fever | 1 | 2007 | 127 | 0.270 |
Why?
|
| Hypoglycemia | 4 | 2001 | 110 | 0.260 |
Why?
|
| Follow-Up Studies | 22 | 2016 | 3698 | 0.250 |
Why?
|
| Thyroiditis | 3 | 2002 | 10 | 0.250 |
Why?
|
| Schizophrenia | 2 | 1999 | 496 | 0.240 |
Why?
|
| Survivors | 2 | 2016 | 191 | 0.230 |
Why?
|
| Cohort Studies | 8 | 2020 | 2891 | 0.230 |
Why?
|
| Lymphatic Metastasis | 9 | 2017 | 498 | 0.230 |
Why?
|
| Schizophrenic Psychology | 3 | 2000 | 136 | 0.220 |
Why?
|
| Fatigue | 2 | 2012 | 176 | 0.220 |
Why?
|
| Rheumatic Fever | 4 | 1998 | 12 | 0.220 |
Why?
|
| Terminology as Topic | 2 | 2015 | 223 | 0.220 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 2 | 2016 | 17 | 0.220 |
Why?
|
| Calcitonin | 15 | 1984 | 38 | 0.220 |
Why?
|
| Survival Rate | 12 | 2016 | 1895 | 0.220 |
Why?
|
| Hypoparathyroidism | 2 | 2002 | 25 | 0.210 |
Why?
|
| Horner Syndrome | 1 | 2002 | 2 | 0.210 |
Why?
|
| Precancerous Conditions | 2 | 1994 | 201 | 0.200 |
Why?
|
| Nerve Compression Syndromes | 1 | 2002 | 19 | 0.200 |
Why?
|
| Pheochromocytoma | 7 | 2010 | 49 | 0.200 |
Why?
|
| Penicillins | 2 | 2001 | 20 | 0.200 |
Why?
|
| Age Factors | 17 | 2016 | 1871 | 0.200 |
Why?
|
| Gastrins | 11 | 1977 | 15 | 0.190 |
Why?
|
| Ultrasonography | 5 | 2017 | 722 | 0.190 |
Why?
|
| Recurrence | 7 | 2014 | 1162 | 0.190 |
Why?
|
| SEER Program | 7 | 2016 | 202 | 0.190 |
Why?
|
| Deoxyribonucleases | 2 | 1998 | 29 | 0.190 |
Why?
|
| Carrier State | 1 | 2001 | 39 | 0.190 |
Why?
|
| Cognition Disorders | 2 | 2005 | 236 | 0.190 |
Why?
|
| Immunoassay | 2 | 2019 | 93 | 0.190 |
Why?
|
| Hyperinsulinism | 1 | 2001 | 48 | 0.190 |
Why?
|
| Preoperative Care | 4 | 2018 | 400 | 0.190 |
Why?
|
| Child, Preschool | 23 | 2001 | 3767 | 0.180 |
Why?
|
| Pancreatic Diseases | 1 | 2001 | 53 | 0.180 |
Why?
|
| Awareness | 2 | 1999 | 88 | 0.180 |
Why?
|
| Liver Neoplasms | 2 | 2007 | 760 | 0.180 |
Why?
|
| Drug Resistance, Microbial | 3 | 2001 | 75 | 0.180 |
Why?
|
| Mutation | 5 | 2008 | 4183 | 0.180 |
Why?
|
| Endocrine System Diseases | 2 | 1999 | 23 | 0.180 |
Why?
|
| T-Lymphocytes | 7 | 1997 | 1229 | 0.180 |
Why?
|
| Insulinoma | 4 | 1990 | 37 | 0.180 |
Why?
|
| Health Status | 3 | 2015 | 370 | 0.180 |
Why?
|
| Pancreatectomy | 2 | 2001 | 164 | 0.180 |
Why?
|
| Interpersonal Relations | 2 | 2000 | 178 | 0.180 |
Why?
|
| Hashimoto Disease | 1 | 2020 | 11 | 0.180 |
Why?
|
| Coordination Complexes | 1 | 2020 | 20 | 0.170 |
Why?
|
| Octreotide | 1 | 2020 | 28 | 0.170 |
Why?
|
| History, 19th Century | 3 | 2009 | 56 | 0.170 |
Why?
|
| Receptors, Thyrotropin | 6 | 1997 | 47 | 0.170 |
Why?
|
| Antibodies | 3 | 1998 | 353 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2015 | 604 | 0.170 |
Why?
|
| Psychometrics | 3 | 2017 | 332 | 0.170 |
Why?
|
| Time Factors | 21 | 2016 | 5366 | 0.160 |
Why?
|
| DNA, Neoplasm | 2 | 1992 | 266 | 0.160 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 92 | 0.160 |
Why?
|
| Hypertension | 3 | 2018 | 746 | 0.160 |
Why?
|
| Clinical Chemistry Tests | 1 | 2019 | 11 | 0.160 |
Why?
|
| Calcium Gluconate | 1 | 2018 | 4 | 0.160 |
Why?
|
| Hyperaldosteronism | 1 | 2018 | 12 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2016 | 1362 | 0.160 |
Why?
|
| Physicians | 2 | 2018 | 690 | 0.160 |
Why?
|
| Chicago | 7 | 2016 | 1441 | 0.160 |
Why?
|
| Prognosis | 18 | 2016 | 3813 | 0.160 |
Why?
|
| History, 20th Century | 3 | 2009 | 315 | 0.160 |
Why?
|
| Duodenal Neoplasms | 3 | 1997 | 19 | 0.150 |
Why?
|
| Rare Diseases | 2 | 2016 | 69 | 0.150 |
Why?
|
| United States | 15 | 2020 | 7142 | 0.150 |
Why?
|
| Streptolysins | 1 | 1998 | 5 | 0.150 |
Why?
|
| Neuroendocrine Tumors | 1 | 2020 | 124 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2000 | 243 | 0.150 |
Why?
|
| Calcitriol | 1 | 2018 | 173 | 0.150 |
Why?
|
| Hepatitis C | 1 | 2000 | 175 | 0.150 |
Why?
|
| Islets of Langerhans | 1 | 2001 | 553 | 0.140 |
Why?
|
| Aged, 80 and over | 15 | 2016 | 6816 | 0.140 |
Why?
|
| Personality | 1 | 1999 | 138 | 0.140 |
Why?
|
| Postoperative Care | 1 | 2018 | 234 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 474 | 0.140 |
Why?
|
| Anemia | 3 | 1997 | 133 | 0.140 |
Why?
|
| Social Perception | 1 | 2018 | 94 | 0.140 |
Why?
|
| Sensitivity and Specificity | 7 | 2014 | 2019 | 0.140 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 288 | 0.140 |
Why?
|
| Intraoperative Complications | 2 | 2016 | 185 | 0.140 |
Why?
|
| Biopsy | 6 | 2002 | 1192 | 0.140 |
Why?
|
| Treatment Outcome | 10 | 2020 | 8379 | 0.140 |
Why?
|
| Radionuclide Imaging | 7 | 2014 | 222 | 0.140 |
Why?
|
| Travel | 1 | 2017 | 72 | 0.140 |
Why?
|
| Electrosurgery | 1 | 2016 | 10 | 0.130 |
Why?
|
| Ultrasonic Surgical Procedures | 1 | 2016 | 6 | 0.130 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 45 | 0.130 |
Why?
|
| Vipoma | 2 | 1986 | 4 | 0.130 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2010 | 28 | 0.130 |
Why?
|
| Stomach | 4 | 1977 | 111 | 0.130 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 121 | 0.130 |
Why?
|
| Intestine, Small | 2 | 1997 | 299 | 0.120 |
Why?
|
| Medical Errors | 1 | 2016 | 115 | 0.120 |
Why?
|
| Mass Screening | 2 | 2018 | 643 | 0.120 |
Why?
|
| Gastric Bypass | 1 | 2016 | 114 | 0.120 |
Why?
|
| Epigenomics | 1 | 2016 | 103 | 0.120 |
Why?
|
| Biological Assay | 2 | 2014 | 81 | 0.120 |
Why?
|
| Acute Disease | 6 | 2002 | 854 | 0.120 |
Why?
|
| Age of Onset | 4 | 2015 | 319 | 0.120 |
Why?
|
| Antibody Formation | 2 | 1994 | 172 | 0.120 |
Why?
|
| Cytokines | 3 | 1997 | 814 | 0.120 |
Why?
|
| Spirituality | 1 | 2015 | 86 | 0.120 |
Why?
|
| Hyperostosis Frontalis Interna | 1 | 2014 | 4 | 0.120 |
Why?
|
| Military Personnel | 1 | 1996 | 92 | 0.120 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 1994 | 6 | 0.120 |
Why?
|
| Thyroid Diseases | 3 | 1997 | 106 | 0.120 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 1994 | 18 | 0.110 |
Why?
|
| Neoplasm Staging | 7 | 2020 | 2019 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 242 | 0.110 |
Why?
|
| Young Adult | 6 | 2016 | 6426 | 0.110 |
Why?
|
| Hominidae | 1 | 1994 | 98 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 473 | 0.100 |
Why?
|
| Primates | 1 | 1994 | 155 | 0.100 |
Why?
|
| Social Behavior | 1 | 2015 | 300 | 0.100 |
Why?
|
| Sex Factors | 8 | 2015 | 1074 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 1998 | 1397 | 0.100 |
Why?
|
| Antigens, CD | 1 | 1994 | 467 | 0.100 |
Why?
|
| Rectal Neoplasms | 3 | 2001 | 129 | 0.100 |
Why?
|
| Bronchogenic Cyst | 1 | 1991 | 5 | 0.100 |
Why?
|
| Adrenal Gland Diseases | 1 | 1991 | 14 | 0.100 |
Why?
|
| Liver | 2 | 2016 | 1218 | 0.100 |
Why?
|
| Gastric Juice | 7 | 1977 | 15 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2012 | 142 | 0.090 |
Why?
|
| Reference Values | 5 | 2016 | 662 | 0.090 |
Why?
|
| Bacterial Proteins | 5 | 1999 | 903 | 0.090 |
Why?
|
| Adrenalectomy | 4 | 2006 | 45 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2016 | 666 | 0.090 |
Why?
|
| Breast Neoplasms | 5 | 2016 | 3020 | 0.090 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 1747 | 0.090 |
Why?
|
| Intraoperative Period | 2 | 2019 | 91 | 0.090 |
Why?
|
| History, 18th Century | 2 | 2009 | 21 | 0.090 |
Why?
|
| Gastrinoma | 1 | 1990 | 2 | 0.090 |
Why?
|
| Syndrome | 3 | 2007 | 452 | 0.090 |
Why?
|
| Adenoids | 2 | 2009 | 9 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 6 | 2000 | 923 | 0.090 |
Why?
|
| Autoimmune Diseases | 3 | 1997 | 252 | 0.090 |
Why?
|
| Multiple Endocrine Neoplasia | 2 | 1990 | 7 | 0.090 |
Why?
|
| Disease Outbreaks | 2 | 1991 | 156 | 0.090 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2015 | 107 | 0.090 |
Why?
|
| Reoperation | 4 | 2002 | 609 | 0.090 |
Why?
|
| Palatine Tonsil | 2 | 2009 | 31 | 0.090 |
Why?
|
| Molecular Sequence Data | 7 | 2008 | 3030 | 0.090 |
Why?
|
| Nuclear Reactors | 1 | 2009 | 7 | 0.090 |
Why?
|
| Malpractice | 1 | 2010 | 57 | 0.090 |
Why?
|
| Base Sequence | 6 | 2008 | 2329 | 0.090 |
Why?
|
| Cushing Syndrome | 4 | 2006 | 24 | 0.090 |
Why?
|
| Prospective Studies | 8 | 2015 | 4348 | 0.080 |
Why?
|
| Penicillin G | 1 | 1989 | 4 | 0.080 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 2 | 2004 | 6 | 0.080 |
Why?
|
| Kidney Calculi | 1 | 2012 | 343 | 0.080 |
Why?
|
| History, 16th Century | 1 | 2009 | 7 | 0.080 |
Why?
|
| Monitoring, Physiologic | 2 | 2002 | 264 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 1993 | 572 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 5 | 2001 | 806 | 0.080 |
Why?
|
| Pregnancy Complications | 3 | 1984 | 344 | 0.080 |
Why?
|
| History, Ancient | 1 | 2009 | 76 | 0.080 |
Why?
|
| Alkalosis | 3 | 1974 | 10 | 0.080 |
Why?
|
| Serotyping | 3 | 2003 | 28 | 0.080 |
Why?
|
| Endocarditis, Bacterial | 4 | 1984 | 38 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2014 | 796 | 0.080 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 419 | 0.080 |
Why?
|
| Case-Control Studies | 4 | 2016 | 1873 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2000 | 497 | 0.080 |
Why?
|
| Depression | 1 | 2012 | 517 | 0.080 |
Why?
|
| Insulin | 7 | 1987 | 1162 | 0.080 |
Why?
|
| Positron-Emission Tomography | 3 | 2020 | 340 | 0.080 |
Why?
|
| Infant | 14 | 1997 | 3184 | 0.080 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2008 | 45 | 0.080 |
Why?
|
| Animals | 32 | 2016 | 27715 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2008 | 73 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1695 | 0.070 |
Why?
|
| Pyrin | 1 | 2007 | 1 | 0.070 |
Why?
|
| Vocal Cord Paralysis | 2 | 2010 | 27 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1549 | 0.070 |
Why?
|
| Chronobiology Phenomena | 1 | 2007 | 4 | 0.070 |
Why?
|
| Combined Modality Therapy | 7 | 2001 | 1709 | 0.070 |
Why?
|
| Parathyroid Diseases | 2 | 1983 | 9 | 0.070 |
Why?
|
| Injections, Intramuscular | 2 | 2001 | 64 | 0.070 |
Why?
|
| Swine | 7 | 2016 | 593 | 0.070 |
Why?
|
| Pre-Eclampsia | 1 | 2010 | 259 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2001 | 478 | 0.070 |
Why?
|
| Intraocular Pressure | 1 | 2007 | 59 | 0.070 |
Why?
|
| Hyperplasia | 5 | 1992 | 153 | 0.070 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2006 | 11 | 0.070 |
Why?
|
| Risk Factors | 5 | 2016 | 5583 | 0.070 |
Why?
|
| Dementia | 2 | 2005 | 205 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 2 | 1999 | 28 | 0.070 |
Why?
|
| Glucagonoma | 1 | 1986 | 1 | 0.070 |
Why?
|
| Somatostatinoma | 1 | 1986 | 1 | 0.070 |
Why?
|
| Pancreatic Polypeptide | 1 | 1986 | 9 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 229 | 0.070 |
Why?
|
| Neuropsychological Tests | 3 | 2005 | 513 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 1999 | 54 | 0.060 |
Why?
|
| Codon | 2 | 1997 | 123 | 0.060 |
Why?
|
| Goiter | 2 | 2002 | 44 | 0.060 |
Why?
|
| Radioimmunoassay | 8 | 1974 | 155 | 0.060 |
Why?
|
| Pancreas | 2 | 1986 | 254 | 0.060 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 2670 | 0.060 |
Why?
|
| Ferric Compounds | 2 | 1996 | 40 | 0.060 |
Why?
|
| Iodine Radioisotopes | 6 | 1995 | 135 | 0.060 |
Why?
|
| Antigens, Bacterial | 2 | 1999 | 136 | 0.060 |
Why?
|
| Behavioral Medicine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 1996 | 465 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2007 | 281 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 1987 | 605 | 0.060 |
Why?
|
| Renal Dialysis | 4 | 2014 | 339 | 0.060 |
Why?
|
| Neoplasms | 3 | 2016 | 3030 | 0.060 |
Why?
|
| Palliative Care | 1 | 2007 | 264 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2005 | 2782 | 0.060 |
Why?
|
| Cholecystokinin | 3 | 1977 | 15 | 0.060 |
Why?
|
| Blood Glucose | 5 | 1987 | 849 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2001 | 291 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2021 | 1500 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 1991 | 726 | 0.060 |
Why?
|
| Pain | 1 | 2007 | 399 | 0.060 |
Why?
|
| Sepsis | 3 | 1991 | 330 | 0.060 |
Why?
|
| Heart Rate | 2 | 2007 | 496 | 0.060 |
Why?
|
| Adenoma, Oxyphilic | 2 | 2013 | 31 | 0.060 |
Why?
|
| Catecholamines | 1 | 2004 | 92 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2005 | 140 | 0.060 |
Why?
|
| Vancomycin | 1 | 1984 | 74 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2422 | 0.060 |
Why?
|
| Neurology | 1 | 2005 | 75 | 0.060 |
Why?
|
| Comorbidity | 2 | 2017 | 955 | 0.060 |
Why?
|
| Registries | 3 | 2021 | 812 | 0.060 |
Why?
|
| Blood Pressure | 3 | 2007 | 906 | 0.060 |
Why?
|
| Sheep | 7 | 1984 | 251 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 305 | 0.060 |
Why?
|
| Pharynx | 3 | 2003 | 44 | 0.060 |
Why?
|
| Aging | 2 | 2007 | 730 | 0.060 |
Why?
|
| Drug Administration Schedule | 2 | 2020 | 866 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1806 | 0.060 |
Why?
|
| Hypokalemia | 2 | 2018 | 23 | 0.060 |
Why?
|
| Anal Canal | 2 | 2001 | 90 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2001 | 282 | 0.050 |
Why?
|
| Prevalence | 3 | 2015 | 1251 | 0.050 |
Why?
|
| Antibodies, Bacterial | 2 | 1997 | 100 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 2705 | 0.050 |
Why?
|
| Infant, Newborn | 7 | 1995 | 2502 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2001 | 151 | 0.050 |
Why?
|
| Pregnancy | 7 | 2010 | 3070 | 0.050 |
Why?
|
| Administration, Oral | 3 | 2001 | 671 | 0.050 |
Why?
|
| Neck Pain | 1 | 2002 | 18 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 1999 | 679 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 259 | 0.050 |
Why?
|
| Bradycardia | 1 | 2002 | 39 | 0.050 |
Why?
|
| Leukemia, Lymphoid | 2 | 1981 | 72 | 0.050 |
Why?
|
| Neck Dissection | 2 | 2016 | 67 | 0.050 |
Why?
|
| Probability | 3 | 1999 | 357 | 0.050 |
Why?
|
| Acidosis | 2 | 1972 | 55 | 0.050 |
Why?
|
| Rats | 13 | 1980 | 4061 | 0.050 |
Why?
|
| Pentagastrin | 3 | 1979 | 4 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 1984 | 272 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 2004 | 270 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 1982 | 279 | 0.050 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2001 | 8 | 0.050 |
Why?
|
| Fecal Incontinence | 1 | 2001 | 59 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2001 | 152 | 0.050 |
Why?
|
| Verapamil | 1 | 2001 | 34 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2001 | 67 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 854 | 0.050 |
Why?
|
| Recombinant Proteins | 4 | 1996 | 1015 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2014 | 591 | 0.050 |
Why?
|
| Wechsler Scales | 1 | 2000 | 21 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2001 | 121 | 0.050 |
Why?
|
| Educational Status | 2 | 2015 | 194 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 388 | 0.040 |
Why?
|
| Histamine | 3 | 1979 | 126 | 0.040 |
Why?
|
| Epitopes | 3 | 1996 | 254 | 0.040 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2000 | 10 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2014 | 898 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 303 | 0.040 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2001 | 105 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 1997 | 1232 | 0.040 |
Why?
|
| Proinsulin | 4 | 1987 | 124 | 0.040 |
Why?
|
| Ego | 1 | 2000 | 4 | 0.040 |
Why?
|
| Propensity Score | 1 | 2021 | 154 | 0.040 |
Why?
|
| Lung Neoplasms | 4 | 1995 | 2370 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2001 | 294 | 0.040 |
Why?
|
| Response Evaluation Criteria in Solid Tumors | 1 | 2020 | 59 | 0.040 |
Why?
|
| Streptococcus | 3 | 1989 | 8 | 0.040 |
Why?
|
| Object Attachment | 1 | 2000 | 19 | 0.040 |
Why?
|
| Hepatitis C Antibodies | 1 | 2000 | 6 | 0.040 |
Why?
|
| Adrenal Glands | 3 | 2004 | 77 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1998 | 374 | 0.040 |
Why?
|
| Models, Economic | 1 | 2020 | 62 | 0.040 |
Why?
|
| Markov Chains | 1 | 2020 | 128 | 0.040 |
Why?
|
| Leukemia | 2 | 1981 | 320 | 0.040 |
Why?
|
| Pancreas Transplantation | 1 | 2000 | 104 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2000 | 87 | 0.040 |
Why?
|
| Phosphorus | 6 | 1982 | 117 | 0.040 |
Why?
|
| Ribonucleases | 1 | 2000 | 93 | 0.040 |
Why?
|
| Immunoglobulin G | 3 | 1997 | 472 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 1980 | 118 | 0.040 |
Why?
|
| Disease Progression | 2 | 2005 | 1486 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 1980 | 303 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2020 | 146 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2001 | 233 | 0.040 |
Why?
|
| Carotid Body | 1 | 2002 | 236 | 0.040 |
Why?
|
| Gastrectomy | 6 | 1979 | 72 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 1980 | 148 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2001 | 548 | 0.040 |
Why?
|
| Canada | 2 | 2015 | 201 | 0.040 |
Why?
|
| Organometallic Compounds | 1 | 2020 | 140 | 0.040 |
Why?
|
| Shock, Septic | 2 | 1997 | 105 | 0.040 |
Why?
|
| Iodide Peroxidase | 2 | 1997 | 212 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2001 | 569 | 0.040 |
Why?
|
| Antithyroid Agents | 3 | 1995 | 23 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2006 | 782 | 0.040 |
Why?
|
| Personality Assessment | 1 | 1999 | 97 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2000 | 131 | 0.040 |
Why?
|
| Thyroglobulin | 3 | 1995 | 59 | 0.040 |
Why?
|
| Phosphates | 2 | 1970 | 161 | 0.040 |
Why?
|
| Cause of Death | 1 | 2000 | 270 | 0.040 |
Why?
|
| Secretin | 4 | 1979 | 6 | 0.040 |
Why?
|
| Length of Stay | 2 | 2018 | 757 | 0.040 |
Why?
|
| Lymph Node Excision | 2 | 2017 | 222 | 0.040 |
Why?
|
| Memory | 1 | 2000 | 221 | 0.040 |
Why?
|
| Injections, Intravenous | 5 | 1996 | 238 | 0.040 |
Why?
|
| Social Adjustment | 1 | 1998 | 47 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2000 | 303 | 0.040 |
Why?
|
| Minnesota | 3 | 1991 | 45 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2016 | 2338 | 0.040 |
Why?
|
| C-Peptide | 3 | 1987 | 184 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 3 | 1973 | 33 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2008 | 3431 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2000 | 498 | 0.040 |
Why?
|
| Neoplasm Metastasis | 4 | 1992 | 1066 | 0.040 |
Why?
|
| Gastrointestinal Hormones | 1 | 1977 | 6 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1995 | 243 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2000 | 349 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 1991 | 1608 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 1999 | 203 | 0.030 |
Why?
|
| Radiotherapy | 2 | 1976 | 318 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 1997 | 39 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1997 | 135 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 1170 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1993 | 39 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2018 | 232 | 0.030 |
Why?
|
| Prostaglandins | 3 | 1973 | 43 | 0.030 |
Why?
|
| Gastric Mucosa | 3 | 1977 | 68 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 245 | 0.030 |
Why?
|
| Hospitals, Military | 1 | 1996 | 3 | 0.030 |
Why?
|
| Medicare | 1 | 2020 | 429 | 0.030 |
Why?
|
| Intestinal Diseases | 1 | 1997 | 79 | 0.030 |
Why?
|
| Chlamydophila pneumoniae | 1 | 1996 | 13 | 0.030 |
Why?
|
| Serotonin | 3 | 1973 | 221 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 1998 | 695 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3486 | 0.030 |
Why?
|
| Body Temperature | 1 | 2016 | 126 | 0.030 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 1996 | 9 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2018 | 313 | 0.030 |
Why?
|
| Plutonium | 1 | 1995 | 1 | 0.030 |
Why?
|
| Radioactive Fallout | 1 | 1995 | 1 | 0.030 |
Why?
|
| Spumavirus | 1 | 1995 | 1 | 0.030 |
Why?
|
| Myometrium | 1 | 1996 | 51 | 0.030 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 1996 | 20 | 0.030 |
Why?
|
| Patient Admission | 1 | 1996 | 113 | 0.030 |
Why?
|
| Community Medicine | 1 | 1975 | 1 | 0.030 |
Why?
|
| Lymphocyte Transfusion | 1 | 1995 | 41 | 0.030 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 218 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2020 | 1103 | 0.030 |
Why?
|
| Comprehensive Health Care | 1 | 1975 | 13 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 158 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 229 | 0.030 |
Why?
|
| Retroviridae Infections | 1 | 1995 | 48 | 0.030 |
Why?
|
| Video-Assisted Surgery | 1 | 2015 | 6 | 0.030 |
Why?
|
| Autoimmunity | 1 | 1996 | 172 | 0.030 |
Why?
|
| Goiter, Substernal | 1 | 1975 | 3 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 1996 | 188 | 0.030 |
Why?
|
| Finland | 1 | 2014 | 28 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1995 | 160 | 0.030 |
Why?
|
| Pancreatitis | 1 | 1975 | 87 | 0.030 |
Why?
|
| Peptic Ulcer | 1 | 1974 | 18 | 0.030 |
Why?
|
| Vena Cava, Superior | 1 | 1975 | 60 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2015 | 112 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2015 | 99 | 0.030 |
Why?
|
| Thymectomy | 1 | 2014 | 31 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 1994 | 21 | 0.030 |
Why?
|
| Frozen Sections | 1 | 2014 | 50 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 464 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 206 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1994 | 67 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 283 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 427 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 63 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 1994 | 83 | 0.030 |
Why?
|
| Global Health | 1 | 2016 | 192 | 0.030 |
Why?
|
| Papio | 1 | 1994 | 82 | 0.030 |
Why?
|
| Communication | 1 | 2018 | 462 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2001 | 2337 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 112 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 109 | 0.030 |
Why?
|
| DNA Primers | 2 | 2008 | 546 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 1996 | 342 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2005 | 234 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 1994 | 1129 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1979 | 482 | 0.030 |
Why?
|
| Autoradiography | 1 | 1993 | 70 | 0.030 |
Why?
|
| Rheumatic Heart Disease | 3 | 1998 | 30 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2000 | 860 | 0.030 |
Why?
|
| Endometrial Neoplasms | 1 | 1996 | 208 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 438 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 888 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 982 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 776 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1996 | 538 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 1216 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 652 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 153 | 0.030 |
Why?
|
| Pylorus | 1 | 1972 | 14 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 625 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 1994 | 205 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2013 | 149 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2016 | 553 | 0.020 |
Why?
|
| Diarrhea | 2 | 1971 | 178 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 781 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 1992 | 198 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 1994 | 467 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 1991 | 39 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1056 | 0.020 |
Why?
|
| Endoscopy | 1 | 2015 | 353 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2013 | 237 | 0.020 |
Why?
|
| Body Weight | 2 | 1989 | 455 | 0.020 |
Why?
|
| Iron | 2 | 1996 | 173 | 0.020 |
Why?
|
| Jurisprudence | 1 | 2010 | 25 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1994 | 705 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 1996 | 1751 | 0.020 |
Why?
|
| Forecasting | 1 | 1991 | 306 | 0.020 |
Why?
|
| Pyoderma | 1 | 1970 | 3 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 1970 | 48 | 0.020 |
Why?
|
| Transplantation, Heterologous | 3 | 1997 | 368 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2001 | 20 | 0.020 |
Why?
|
| Body Surface Area | 1 | 1989 | 36 | 0.020 |
Why?
|
| Stomach Diseases | 1 | 1969 | 19 | 0.020 |
Why?
|
| Duodenal Diseases | 1 | 1969 | 23 | 0.020 |
Why?
|
| Pedigree | 2 | 2004 | 969 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 1970 | 76 | 0.020 |
Why?
|
| Robotic Surgical Procedures | 1 | 2015 | 322 | 0.020 |
Why?
|
| Bicarbonates | 3 | 1974 | 58 | 0.020 |
Why?
|
| Hormones | 1 | 1969 | 139 | 0.020 |
Why?
|
| Lymphocyte Activation | 3 | 1996 | 756 | 0.020 |
Why?
|
| Random Allocation | 1 | 1989 | 327 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2008 | 147 | 0.020 |
Why?
|
| Receptors, Dopamine | 1 | 1988 | 37 | 0.020 |
Why?
|
| Gallbladder | 1 | 1968 | 32 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1974 | 504 | 0.020 |
Why?
|
| Bile | 1 | 1968 | 60 | 0.020 |
Why?
|
| Dopamine Agents | 1 | 1988 | 28 | 0.020 |
Why?
|
| Ploidies | 1 | 1987 | 41 | 0.020 |
Why?
|
| Clone Cells | 2 | 1998 | 215 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 355 | 0.020 |
Why?
|
| Benzazepines | 1 | 1988 | 64 | 0.020 |
Why?
|
| Exotoxins | 2 | 1997 | 21 | 0.020 |
Why?
|
| Nevada | 1 | 1987 | 3 | 0.020 |
Why?
|
| Idaho | 1 | 1987 | 8 | 0.020 |
Why?
|
| Utah | 1 | 1987 | 9 | 0.020 |
Why?
|
| Wyoming | 1 | 1987 | 7 | 0.020 |
Why?
|
| Supine Position | 1 | 2007 | 30 | 0.020 |
Why?
|
| Posture | 1 | 2007 | 125 | 0.020 |
Why?
|
| Choristoma | 1 | 1987 | 68 | 0.020 |
Why?
|
| Manometry | 2 | 2001 | 44 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 875 | 0.020 |
Why?
|
| Cell Line | 3 | 1995 | 2505 | 0.020 |
Why?
|
| Glucaric Acid | 2 | 1996 | 5 | 0.020 |
Why?
|
| Galactorrhea | 1 | 1986 | 6 | 0.020 |
Why?
|
| Dopamine | 1 | 1988 | 277 | 0.020 |
Why?
|
| Portal System | 1 | 1966 | 13 | 0.020 |
Why?
|
| Mice, SCID | 2 | 1997 | 260 | 0.020 |
Why?
|
| Amenorrhea | 1 | 1986 | 28 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 1991 | 1738 | 0.020 |
Why?
|
| Sodium Chloride | 2 | 1977 | 88 | 0.020 |
Why?
|
| Psychological Tests | 1 | 1986 | 91 | 0.020 |
Why?
|
| Erythropoietin | 2 | 1996 | 90 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2008 | 683 | 0.020 |
Why?
|
| Dental Plaque | 1 | 1984 | 2 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 1985 | 119 | 0.020 |
Why?
|
| Metanephrine | 1 | 2004 | 6 | 0.020 |
Why?
|
| MMPI | 1 | 1964 | 10 | 0.010 |
Why?
|
| Iodine Isotopes | 2 | 1973 | 18 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2005 | 120 | 0.010 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2004 | 20 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1987 | 198 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1984 | 77 | 0.010 |
Why?
|
| Propylthiouracil | 2 | 1979 | 27 | 0.010 |
Why?
|
| Cats | 1 | 1984 | 305 | 0.010 |
Why?
|
| Labor, Obstetric | 1 | 2004 | 46 | 0.010 |
Why?
|
| Body Image | 1 | 1964 | 80 | 0.010 |
Why?
|
| Gluconates | 3 | 1975 | 13 | 0.010 |
Why?
|
| Phenotype | 2 | 2001 | 2473 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 160 | 0.010 |
Why?
|
| Magnesium | 2 | 1975 | 178 | 0.010 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1984 | 72 | 0.010 |
Why?
|
| Iran | 1 | 2003 | 15 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1161 | 0.010 |
Why?
|
| Rabbits | 1 | 1984 | 641 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 1995 | 2409 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 73 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 170 | 0.010 |
Why?
|
| Duodenal Ulcer | 2 | 1973 | 11 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 198 | 0.010 |
Why?
|
| Methods | 1 | 1982 | 151 | 0.010 |
Why?
|
| Breast | 1 | 1964 | 289 | 0.010 |
Why?
|
| Thyroid Function Tests | 1 | 1963 | 124 | 0.010 |
Why?
|
| Radiometry | 1 | 1963 | 57 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 2 | 1983 | 100 | 0.010 |
Why?
|
| Technetium | 1 | 1982 | 29 | 0.010 |
Why?
|
| Maryland | 2 | 1981 | 43 | 0.010 |
Why?
|
| Hydrochloric Acid | 2 | 1972 | 11 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1695 | 0.010 |
Why?
|
| Mediastinal Neoplasms | 1 | 1982 | 45 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1982 | 85 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 2 | 1973 | 34 | 0.010 |
Why?
|
| Kinetics | 1 | 1984 | 1550 | 0.010 |
Why?
|
| Students | 1 | 2003 | 172 | 0.010 |
Why?
|
| Echocardiography | 1 | 1987 | 947 | 0.010 |
Why?
|
| Research | 1 | 1963 | 252 | 0.010 |
Why?
|
| Radiotherapy Dosage | 3 | 1994 | 468 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1983 | 263 | 0.010 |
Why?
|
| Erythromycin | 1 | 2001 | 10 | 0.010 |
Why?
|
| Chile | 1 | 2001 | 7 | 0.010 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2001 | 49 | 0.010 |
Why?
|
| Clindamycin | 1 | 2001 | 15 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1963 | 234 | 0.010 |
Why?
|
| Heart Defects, Congenital | 2 | 1979 | 367 | 0.010 |
Why?
|
| Psychoanalytic Interpretation | 1 | 2000 | 1 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1963 | 208 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 2000 | 59 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2000 | 88 | 0.010 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 1980 | 8 | 0.010 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2000 | 57 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1979 | 51 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2000 | 106 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 748 | 0.010 |
Why?
|
| Socioeconomic Factors | 2 | 1981 | 595 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1987 | 1061 | 0.010 |
Why?
|
| Methimazole | 1 | 1979 | 13 | 0.010 |
Why?
|
| Veterans | 1 | 2000 | 86 | 0.010 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 1979 | 14 | 0.010 |
Why?
|
| Propranolol | 1 | 1979 | 43 | 0.010 |
Why?
|
| Premedication | 1 | 1979 | 57 | 0.010 |
Why?
|
| Laboratories | 1 | 1999 | 44 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1963 | 419 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2000 | 160 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 290 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1974 | 27 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2001 | 388 | 0.010 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1997 | 17 | 0.010 |
Why?
|
| Gallium Radioisotopes | 1 | 1977 | 31 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1997 | 20 | 0.010 |
Why?
|
| Chimera | 1 | 1997 | 56 | 0.010 |
Why?
|
| Pharyngeal Diseases | 1 | 1997 | 11 | 0.010 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1997 | 13 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1979 | 117 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2000 | 1000 | 0.010 |
Why?
|
| North Carolina | 1 | 1997 | 50 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 1997 | 44 | 0.010 |
Why?
|
| India | 1 | 1998 | 123 | 0.010 |
Why?
|
| Sodium | 2 | 1970 | 334 | 0.010 |
Why?
|
| Soft Tissue Infections | 1 | 1997 | 26 | 0.010 |
Why?
|
| Learning | 1 | 2000 | 287 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1997 | 54 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 399 | 0.010 |
Why?
|
| Patient Selection | 1 | 2001 | 682 | 0.010 |
Why?
|
| Autoantibodies | 2 | 1995 | 275 | 0.010 |
Why?
|
| Risk | 1 | 1979 | 656 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1977 | 15 | 0.010 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 1977 | 9 | 0.010 |
Why?
|
| Abscess | 1 | 1997 | 95 | 0.010 |
Why?
|
| Epidemiologic Factors | 1 | 1997 | 5 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1997 | 218 | 0.010 |
Why?
|
| History, 17th Century | 1 | 1997 | 11 | 0.010 |
Why?
|
| Interleukins | 1 | 1997 | 132 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 200 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1998 | 477 | 0.010 |
Why?
|
| Superantigens | 1 | 1997 | 24 | 0.010 |
Why?
|
| Th1 Cells | 1 | 1997 | 166 | 0.010 |
Why?
|
| Autoantigens | 1 | 1997 | 132 | 0.010 |
Why?
|
| Office Visits | 1 | 1997 | 50 | 0.010 |
Why?
|
| Bacteremia | 1 | 1997 | 103 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1997 | 65 | 0.010 |
Why?
|
| Glucose | 1 | 1979 | 635 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 1996 | 17 | 0.010 |
Why?
|
| Calcium Chloride | 2 | 1975 | 10 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1996 | 167 | 0.010 |
Why?
|
| Micronesia | 1 | 1995 | 5 | 0.010 |
Why?
|
| Body Burden | 1 | 1995 | 10 | 0.010 |
Why?
|
| Ferritins | 1 | 1996 | 29 | 0.010 |
Why?
|
| Genes, gag | 1 | 1995 | 7 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1996 | 111 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1997 | 277 | 0.010 |
Why?
|
| DNA Probes | 1 | 1995 | 77 | 0.010 |
Why?
|
| Urinalysis | 1 | 1995 | 31 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1997 | 449 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1976 | 73 | 0.010 |
Why?
|
| Cattle | 1 | 1976 | 379 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1996 | 204 | 0.010 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 1995 | 5 | 0.010 |
Why?
|
| Radiation Effects | 1 | 1975 | 28 | 0.010 |
Why?
|
| Constriction | 1 | 1975 | 27 | 0.010 |
Why?
|
| Morbidity | 1 | 1995 | 151 | 0.010 |
Why?
|
| Glucagon | 1 | 1975 | 113 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 1995 | 51 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1976 | 160 | 0.010 |
Why?
|
| Phlebography | 1 | 1975 | 70 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1995 | 265 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1974 | 120 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 1995 | 231 | 0.010 |
Why?
|
| Leukocytes | 1 | 1995 | 209 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1976 | 526 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1996 | 570 | 0.010 |
Why?
|
| Neutrophils | 1 | 1976 | 313 | 0.010 |
Why?
|
| Neck | 1 | 1975 | 104 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1995 | 302 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1247 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1998 | 544 | 0.010 |
Why?
|
| Calcium Carbonate | 1 | 1973 | 4 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1995 | 358 | 0.010 |
Why?
|
| Shock, Surgical | 1 | 1973 | 1 | 0.010 |
Why?
|
| Intestinal Absorption | 2 | 1973 | 125 | 0.010 |
Why?
|
| Monocytes | 1 | 1995 | 222 | 0.010 |
Why?
|
| Kallikreins | 1 | 1973 | 46 | 0.010 |
Why?
|
| Cell Division | 1 | 1995 | 692 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1973 | 24 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1992 | 28 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1975 | 291 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1972 | 22 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 127 | 0.010 |
Why?
|
| Anura | 2 | 1971 | 21 | 0.010 |
Why?
|
| Mice | 2 | 1997 | 11949 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1988 | 1935 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 125 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1992 | 62 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1972 | 12 | 0.010 |
Why?
|
| Postoperative Period | 2 | 1983 | 301 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1973 | 244 | 0.010 |
Why?
|
| Malignant Carcinoid Syndrome | 1 | 1972 | 4 | 0.010 |
Why?
|
| Malabsorption Syndromes | 1 | 1972 | 21 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1973 | 397 | 0.010 |
Why?
|
| Reference Standards | 1 | 1992 | 143 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1994 | 795 | 0.010 |
Why?
|
| Intestines | 1 | 1975 | 416 | 0.010 |
Why?
|
| Neurofibromatosis 1 | 1 | 1972 | 39 | 0.010 |
Why?
|
| Veins | 1 | 1972 | 95 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1971 | 108 | 0.010 |
Why?
|
| Colorado | 1 | 1991 | 37 | 0.010 |
Why?
|
| Ileum | 1 | 1972 | 168 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1972 | 117 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 2077 | 0.010 |
Why?
|
| Salicylates | 1 | 1971 | 25 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1995 | 602 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 1970 | 21 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1972 | 151 | 0.010 |
Why?
|
| Decision Making | 1 | 1996 | 672 | 0.010 |
Why?
|
| Vitamin D | 1 | 1973 | 269 | 0.010 |
Why?
|
| Virulence | 1 | 1991 | 282 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1971 | 104 | 0.010 |
Why?
|
| Anuria | 1 | 1970 | 6 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 1970 | 13 | 0.010 |
Why?
|
| Bacteriuria | 1 | 1970 | 10 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1970 | 80 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 2895 | 0.010 |
Why?
|
| Bone Development | 1 | 1970 | 37 | 0.010 |
Why?
|
| Indians, North American | 1 | 1970 | 47 | 0.010 |
Why?
|
| Kidney | 1 | 1975 | 1150 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 168 | 0.010 |
Why?
|
| Edema | 1 | 1970 | 71 | 0.010 |
Why?
|
| Proteinuria | 1 | 1970 | 68 | 0.010 |
Why?
|
| Desoxycorticosterone | 1 | 1969 | 18 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1970 | 116 | 0.010 |
Why?
|
| Hematuria | 1 | 1970 | 50 | 0.010 |
Why?
|
| Gastric Acidity Determination | 1 | 1969 | 2 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1973 | 739 | 0.010 |
Why?
|
| Epinephrine | 1 | 1969 | 89 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1969 | 119 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1970 | 195 | 0.000 |
Why?
|
| Cricetinae | 1 | 1970 | 560 | 0.000 |
Why?
|
| Creatinine | 1 | 1970 | 295 | 0.000 |
Why?
|
| Duodenum | 1 | 1969 | 105 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1972 | 298 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1969 | 121 | 0.000 |
Why?
|
| Dogs | 1 | 1969 | 704 | 0.000 |
Why?
|
| Fenoldopam | 1 | 1988 | 3 | 0.000 |
Why?
|
| Water | 1 | 1970 | 287 | 0.000 |
Why?
|
| Oxygen | 1 | 1973 | 747 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1968 | 102 | 0.000 |
Why?
|
| Water-Electrolyte Balance | 1 | 1968 | 67 | 0.000 |
Why?
|
| Hyperthyroidism | 1 | 1968 | 76 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1969 | 302 | 0.000 |
Why?
|
| Chlorides | 1 | 1968 | 104 | 0.000 |
Why?
|
| Hematocrit | 2 | 1979 | 68 | 0.000 |
Why?
|
| Potassium | 1 | 1968 | 258 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1966 | 38 | 0.000 |
Why?
|
| Iron Isotopes | 1 | 1966 | 1 | 0.000 |
Why?
|
| Mental Status Schedule | 1 | 1986 | 25 | 0.000 |
Why?
|
| Acid Phosphatase | 1 | 1985 | 34 | 0.000 |
Why?
|
| Calcium, Dietary | 2 | 1980 | 64 | 0.000 |
Why?
|
| Castration | 1 | 1985 | 37 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1985 | 137 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1972 | 776 | 0.000 |
Why?
|
| Blood Proteins | 2 | 1979 | 149 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1970 | 807 | 0.000 |
Why?
|
| Hepatectomy | 1 | 1966 | 177 | 0.000 |
Why?
|
| Blood Volume | 2 | 1973 | 48 | 0.000 |
Why?
|
| Dental Care | 1 | 1983 | 12 | 0.000 |
Why?
|
| Mitral Valve Prolapse | 1 | 1983 | 24 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1966 | 498 | 0.000 |
Why?
|
| Iodine | 2 | 1970 | 44 | 0.000 |
Why?
|
| Bone Neoplasms | 1 | 1985 | 321 | 0.000 |
Why?
|
| Sodium Pertechnetate Tc 99m | 1 | 1982 | 1 | 0.000 |
Why?
|
| Bronchial Neoplasms | 1 | 1982 | 9 | 0.000 |
Why?
|
| Hypothyroidism | 1 | 1984 | 263 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1992 | 2525 | 0.000 |
Why?
|
| Thyroxine | 2 | 1975 | 375 | 0.000 |
Why?
|
| Metiamide | 1 | 1979 | 2 | 0.000 |
Why?
|
| Atropine | 1 | 1979 | 60 | 0.000 |
Why?
|
| Bacteria | 1 | 1983 | 488 | 0.000 |
Why?
|
| Protein Binding | 2 | 1975 | 1500 | 0.000 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1977 | 70 | 0.000 |
Why?
|
| Parity | 1 | 1977 | 97 | 0.000 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1977 | 110 | 0.000 |
Why?
|
| Blood Volume Determination | 1 | 1955 | 14 | 0.000 |
Why?
|
| Microsomes | 1 | 1975 | 35 | 0.000 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1975 | 187 | 0.000 |
Why?
|
| Acne Vulgaris | 1 | 1975 | 35 | 0.000 |
Why?
|
| Albumins | 1 | 1955 | 135 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1975 | 197 | 0.000 |
Why?
|
| Conjunctiva | 1 | 1973 | 19 | 0.000 |
Why?
|
| Central Venous Pressure | 1 | 1973 | 26 | 0.000 |
Why?
|
| Immune Sera | 1 | 1973 | 52 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1973 | 63 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1973 | 132 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1973 | 172 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1973 | 103 | 0.000 |
Why?
|
| Pulmonary Circulation | 1 | 1973 | 90 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1973 | 154 | 0.000 |
Why?
|
| Eye Diseases | 1 | 1973 | 59 | 0.000 |
Why?
|
| Chickens | 1 | 1973 | 212 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1973 | 205 | 0.000 |
Why?
|
| Arteries | 1 | 1973 | 179 | 0.000 |
Why?
|
| Pennsylvania | 1 | 1972 | 96 | 0.000 |
Why?
|
| Theophylline | 1 | 1971 | 34 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1970 | 124 | 0.000 |
Why?
|
| Femur | 1 | 1970 | 112 | 0.000 |
Why?
|
| Sports | 1 | 1966 | 40 | 0.000 |
Why?
|